Corteva, Inc. $CTVA Shares Sold by Comerica Bank

Comerica Bank decreased its position in shares of Corteva, Inc. (NYSE:CTVA) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 248,243 shares of the company’s stock after selling 12,068 shares during the period. Comerica Bank’s holdings in Corteva were worth $16,640,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in CTVA. Brighton Jones LLC increased its position in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the period. Woodline Partners LP increased its position in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after buying an additional 16,644 shares during the period. EverSource Wealth Advisors LLC increased its position in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC increased its position in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new position in Corteva during the second quarter worth approximately $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Down 0.6%

CTVA opened at $78.95 on Wednesday. The business’s fifty day moving average is $80.26 and its two-hundred day moving average is $71.94. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a market cap of $53.00 billion, a price-to-earnings ratio of 49.97, a PEG ratio of 2.72 and a beta of 0.68. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts anticipate that Corteva, Inc. will post 3.62 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is presently 45.57%.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CTVA. Jefferies Financial Group boosted their target price on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Mizuho boosted their target price on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Berenberg Bank boosted their target price on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, UBS Group boosted their target price on Corteva from $80.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, April 9th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $85.19.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.